课题基金 / 基金详情

MOLECULAR MARKERS FOR SQUAMOUS CELL CARCINOMA

MOLECULAR MARKERS FOR SQUAMOUS CELL CARCINOMA
鳞状细胞癌的分子标记
批准号:
6352856
负责人:
ADEL K. EL-NAGGAR
金额:
$4.52万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-09-30 至 2001-07-31

项目摘要

项目成果

ADEL K. EL-NAGGAR的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Squamous cell carcinoma (SCC) is the most common malignancy of the oral cavity. Failure to diagnose and treat early lesions, despite their well defined histopathologic criteria and accessibility to clinical detection, underlies the advanced presentation and the significant morbidity and mortality of patients with this cancer. Since the development and progression of neoplasms result from continuous accumulation of various genetic alterations, identifying genetic markers associated with early, intermediate and advanced oral squamous lesions will have important diagnostic and clinical implications. p53 gene and, based on our preliminary data, selected chromosomal loci with emphasis on the refined mapping of 3p21, 8p21, 9p21 and 11p15.5 regions by microsatellite markers will be analyzed on microdissected samples of normal and dysplastic epithelium and invasive lesions from each specimen. In the first phase of the study, samples from 100 retrospective cases will form our materials to determine the highest and most consistent markers for each pathomorphologic stage. In the second phase, each of 20/year prospectively resected specimens will be carefully and systematically mapped for multiple spatially separate samples of normal, different pre- malignant epithelium and malignant lesions to determine clonal progression, stability and heterogeneity of the selected markers. The results will be correlated with histopathologic progression, aggressive tumor characteristics and epidemiological factors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tumor Model and Biospecimen Repository Core
Tumor Model and Biospecimen Repository Core
Molecular and Epidemiologic Characterization of Salivary Gland Carcinomas
Salivary Gland Tumor Cell Biorepository
国内基金
海外基金
Markers 基因集检测技术在神经母细胞瘤中的应用
基于中空纤维细胞/靶标捕获和液相微萃取的中药Q-markers辨析新方法研究
  • 批准号:
    81973287
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2019
  • 负责人:
    胡爽
  • 依托单位:
中药注射剂(丹红注射液)“量-稳-活-代”多维“质控markers”的辨析研究
  • 批准号:
    81503239
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2015
  • 负责人:
    杨静
  • 依托单位: